Evidence-based. Oncologist-approved." title="" class="btn" data-container="body" data-html="true" data-id="425695" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#b3d4fc" tabindex="0" data-original-title="Outcomes4Me"> 1,158 5,977
Activities
Technologies
Entity types
Location
One Beacon Street, 1 Beacon St, Boston, MA 02108, USA
Boston
United States of America
Employees
Scale: 11-50
Estimated: 30
Engaged catalyst
3Added in Motherbase
2 years agoOn a mission to democratize cancer patient care, one life at a time.
Outcomes4Me uses AI and machine learning to help cancer patients navigate their care and access personalized treatment information. When patients provide their health information, our free platform offers both doctor-approved and FDA-approved guidance based on their diagnosis, as well as relevant clinical trials and genetic testing the patient should consider. We are the first digital platform to integrate with the with the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), from the not-for-profit alliance of 33 leading cancer centers. Recent accolades include: 2024 Fast Company World Changing Idea, 2024 MedTech Breakthrough Award, 2024 Inc. Regionals Northeast, 2024 Anthem Award, 2024 BuiltIn Best Place to Work, and the MassTLC Tech Top 50: CEO of the Year Award.
Digital health, breast cancer, Patient outcomes, lung cancer, prostate cancer, patient navigation, clinical trials, real world evidence, and oncology
Award-winning cancer app and patient community with FDA-approved treatment guidance. One of the best app resources for cancer patients. Available on iOS, Android, and the web. Free access to evidence-based and oncologist-approved cancer resources, including: treatment options, research updates, symptom or medication management.
Catalyst | Type | Tweets | Articles | |
---|---|---|---|---|
![]() AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | Other 12 May 2023 | | |
![]() Novartis Pharmaceutical, Pharmaceutical Manufacturing | Novartis Pharmaceutical, Pharmaceutical Manufacturing | Other 2 Apr 2023 | | |
![]() La French Tech Media, Government Administration | La French Tech Media, Government Administration | Other 11 Dec 2020 | |